Back to FMR LLC FMR LLC

RNAC

Showing 8 of 9 quarters

Position history for FMR LLCFMR LLC's holdings in Cartesian Therapeutics, Inc.

Yes. FMR holds 368,429 shares of RNAC (Cartesian Therapeutics), worth $3.8M, as of its Q2 2026 13F filing. It reduced the position by 431,314 shares (-53.9%) from Q1 2026. FMR has held RNAC in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$3.8M

Current Shares

368,429

Total Value Change

-$42.1M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
368,429
-53.9%
$3.8M0.0%$10.42
0
2026-Q1
Decreased
799,743
-41.5%
$4.9M0.0%$6.15
0
2025-Q4
Decreased
1.4M
-36.6%
$9.9M0.0%$7.21
0
2025-Q3
Decreased
2.2M
-7.6%
$22M0.0%$10.22
0
2025-Q2
Decreased
2.3M
-0.3%
$24.3M0.0%$10.39
0
2025-Q1
Decreased
2.3M
-3.4%
$30.8M0.0%$13.18
0
2024-Q4
Decreased
2.4M
-15.0%
$43.4M0.0%$17.91
0
2024-Q3
Increased
2.9M
+458.3%
$46M0.0%$16.12
47

Other major holders of RNAC: Squarepoint Ops LLC, BlackRock, Inc., BlackRock Finance, Inc.

Optional analytics helps us improve. How it’s used